MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 341602 | Name: Wedelin

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Wedelin is a biochemical.

Chemical Structure

Wedelin
Wedelin
CAS#89353-61-7

Theoretical Analysis

MedKoo Cat#: 341602

Name: Wedelin

CAS#: 89353-61-7

Chemical Formula: C40H55NO13

Exact Mass: 757.3673

Molecular Weight: 757.87

Elemental Analysis: C, 63.39; H, 7.32; N, 1.85; O, 27.44

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Wedelin.
IUPAC/Chemical Name
3-beta-28-(beta-D-Glucopyranosyloxy)-28-oxo-olean-12-en-3-yl-beta-D-galactopyranosiduronic acid
InChi Key
KORXNOWCVVACSW-YABYRKKLSA-N
InChi Code
InChI=1S/C40H55NO13/c1-21(2)16-28(43)41-30-32(54-29(44)11-10-23-8-6-5-7-9-23)31(45)25(19-42)53-34(30)52-24-17-37(4)26-13-15-39(51)20-38(26,33(46)22(39)3)14-12-27(37)40(18-24,35(47)48)36(49)50/h5-9,21,24-27,30-34,42,45-46,51H,3,10-20H2,1-2,4H3,(H,41,43)(H,47,48)(H,49,50)/t24-,25+,26-,27-,30+,31+,32+,33-,34+,37-,38+,39-/m0/s1
SMILES Code
C=C([C@@](CC1)(O)C2)[C@H](O)[C@@]32CC[C@]4([H])C(C(O)=O)(C(O)=O)C[C@@H](O[C@H]5[C@H](NC(CC(C)C)=O)[C@H]([C@@H]([C@@H](CO)O5)O)OC(CCC6=CC=CC=C6)=O)C[C@@]4(C)[C@@]31[H]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 757.87 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Gennemark P, Wedelin D. ODEion--a software module for structural identification of ordinary differential equations. J Bioinform Comput Biol. 2014 Feb;12(1):1350015. doi: 10.1142/S0219720013500157. Epub 2013 Nov 12. PubMed PMID: 24467754. 2: Gennemark P, Wedelin D. Benchmarks for identification of ordinary differential equations from time series data. Bioinformatics. 2009 Mar 15;25(6):780-6. doi: 10.1093/bioinformatics/btp050. Epub 2009 Jan 28. PubMed PMID: 19176548; PubMed Central PMCID: PMC2654804. 3: Gennemark P, Wedelin D. Efficient algorithms for ordinary differential equation model identification of biological systems. IET Syst Biol. 2007 Mar;1(2):120-9. PubMed PMID: 17441553. 4: Gennemark P, Nordlander B, Hohmann S, Wedelin D. A simple mathematical model of adaptation to high osmolarity in yeast. In Silico Biol. 2006;6(3):193-214. PubMed PMID: 16922683. 5: Landgren O, Axdorph U, Fears TR, Porwit-MacDonald A, Wedelin C, Björkholm M. A population-based cohort study on early-stage Hodgkin lymphoma treated with radiotherapy alone: with special reference to older patients. Ann Oncol. 2006 Aug;17(8):1290-5. Epub 2006 Jun 1. PubMed PMID: 16740597. 6: Landgren O, Porwit MacDonald A, Tani E, Czader M, Grimfors G, Skoog L, Ost A, Wedelin C, Axdorph U, Svedmyr E, Björkholm M. A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomas. Hematol J. 2004;5(1):69-76. PubMed PMID: 14745433. 7: Landgren O, Algernon C, Axdorph U, Nilsson B, Wedelin C, Porwit-MacDonald A, Grimfors G, Björkholm M. Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis. Haematologica. 2003 Apr;88(4):438-44. PubMed PMID: 12681971. 8: Gårdlund B, Rimeika D, Wedelin B, Laska J. Preoperative bacterial colonization of the upper airways does not predict postoperative airway infection in children. Acta Paediatr. 1998 Apr;87(4):375-7. PubMed PMID: 9628289. 9: Tullgren O, Grimfors G, Holm G, Johansson B, Svedmyr E, Wedelin C, Mellstedt H, Merk K, Björkholm M. Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease. A long-term follow-up. Cancer. 1991 Aug 15;68(4):768-75. PubMed PMID: 1855177. 10: Paul C, Tidefelt U, Gahrton G, Björkholm M, Järnmark M, Killander A, Kimby E, Liliemark J, Lindeberg A, Lindquist R, Lockner D, Lönnqvist B, Mellstedt H, Merk K, Palmblad J, Peterson C, Simonsson B, Stalfelt AM, Sundström C, Wadman B, Wedelin C, Udén AM, Öberg G, Öst Å. A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia. Leuk Lymphoma. 1991;3(5-6):355-64. doi: 10.3109/10428199109070279. PubMed PMID: 27467426. 11: Mellstedt H, Frödin JE, Lindemalm C, Masucci G, Merk K, Pettersson D, Ragnhammar P, Steinitz M, Wedelin C, Wersäll P, et al. Biologic response modifiers in the treatment of gastrointestinal malignancies. Scand J Gastroenterol. 1989 Apr;24(3):257-68. Review. PubMed PMID: 2660246. 12: Mellstedt H, Frödin JE, Masucci G, Lindemalm C, Wedelin C, Christensson B, Shetye J, Biberfeld P, Lefvert AK, Pihlstedt P, et al. Monoclonal antibodies (MAb 17-1A) for the treatment of patients with metastatic colorectal carcinomas. Acta Chir Scand Suppl. 1989;549:63-70. PubMed PMID: 2929214. 13: Wedelin C, Björkholm M, Mellstedt H, Gahrton G, Holm G. Clinical findings and prognostic factors in chronic myeloid leukemias. Acta Med Scand. 1986;220(3):255-60. PubMed PMID: 3465200. 14: Ohqvist G, Settergren G, Tuppurainen T, Anjou Lindskog E, Fischerström A, Torssell L, Wedelin B, Wickerts CJ. Circulatory effects of pancuronium and alcuronium in patients with coronary artery stenosis. Acta Anaesthesiol Scand. 1985 Jan;29(1):22-5. PubMed PMID: 3872001. 15: Björkholm M, Wedelin C, Holm G, Essy-Ehsing B. Familial longevity and prognosis in Hodgkin's disease. Cancer. 1984 Sep 15;54(6):1088-92. PubMed PMID: 6467134. 16: Wedelin C, Björkholm M, Biberfeld P, Holm G, Johansson B, Mellstedt H. Prognostic factors in Hodgkin's disease with special reference to age. Cancer. 1984 Mar 1;53(5):1202-8. PubMed PMID: 6692308. 17: Wedelin C, Björkholm M, Johansson B, Mellstedt H. Clinical and laboratory findings in untreated patients with Hodgkin's disease with special reference to age. Med Oncol Tumor Pharmacother. 1984;1(1):33-41. PubMed PMID: 6544357. 18: Anjou-Lindskog E, Broman L, Holmgren A, Wedelin B. Effects of prenalterol on central haemodynamics and VA/Q distribution early after open-heart surgery. Acta Anaesthesiol Scand. 1983 Apr;27(2):142-8. PubMed PMID: 6837248. 19: Björkholm M, Wedelin C, Holm G, Ericsson H, Nilsson P, Mellstedt H. Lymphocytotoxic serum factors and lymphocyte functions in untreated Hodgkin's disease. Cancer. 1982 Nov 15;50(10):2044-8. PubMed PMID: 7127249. 20: Björkholm M, Wedelin C, Holm G, Ogenstad S, Johansson B, Mellstedt H. Immune status of untreated patients with Hodgkin's disease and prognosis. Cancer Treat Rep. 1982 Apr;66(4):701-9. PubMed PMID: 7074640.

View History

JWH-180

JWH-180